BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17894469)

  • 1. Optimization of a microarray sandwich-ELISA against hINF-gamma on a modified nitrocellulose membrane.
    Reck M; Stahl F; Walter JG; Hollas M; Melzner D; Scheper T
    Biotechnol Prog; 2007; 23(6):1498-505. PubMed ID: 17894469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immobilization strategies for single-chain antibody microarrays.
    Seurynck-Servoss SL; Baird CL; Miller KD; Pefaur NB; Gonzalez RM; Apiyo DO; Engelmann HE; Srivastava S; Kagan J; Rodland KD; Zangar RC
    Proteomics; 2008 Jun; 8(11):2199-210. PubMed ID: 18452230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein A-based antibody immobilization onto polymeric microdevices for enhanced sensitivity of enzyme-linked immunosorbent assay.
    Yuan Y; He H; Lee LJ
    Biotechnol Bioeng; 2009 Feb; 102(3):891-901. PubMed ID: 18942150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fast and reliable protein microarray production by a new drop-in-drop technique.
    Gutmann O; Kuehlewein R; Reinbold S; Niekrawietz R; Steinert CP; de Heij B; Zengerle R; Daub M
    Lab Chip; 2005 Jun; 5(6):675-81. PubMed ID: 15915261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A protein microarray ELISA for screening biological fluids.
    Varnum SM; Woodbury RL; Zangar RC
    Methods Mol Biol; 2004; 264():161-72. PubMed ID: 15020788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a sensitive microarray immunoassay and comparison with standard enzyme-linked immunoassay for cytokine analysis.
    Knight PR; Sreekumar A; Siddiqui J; Laxman B; Copeland S; Chinnaiyan A; Remick DG
    Shock; 2004 Jan; 21(1):26-30. PubMed ID: 14676680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of sandwich ELISA microarrays with minimal assay interference.
    Gonzalez RM; Seurynck-Servoss SL; Crowley SA; Brown M; Omenn GS; Hayes DF; Zangar RC
    J Proteome Res; 2008 Jun; 7(6):2406-14. PubMed ID: 18422355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of antibodies and microarray coatings as a prerequisite for the generation of optimized antibody microarrays.
    Angenendt P; Glökler J
    Methods Mol Biol; 2004; 264():123-34. PubMed ID: 15020785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of miniaturized immunoassay: influence of surface chemistry and comparison with enzyme-linked immunosorbent assay and Western blot.
    El Khoury G; Laurenceau E; Chevolot Y; Mérieux Y; Desbos A; Fabien N; Rigal D; Souteyrand E; Cloarec JP
    Anal Biochem; 2010 May; 400(1):10-8. PubMed ID: 20079705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of an antibody microarray based on agarose-coated slides.
    Lv LL; Liu BC; Zhang CX; Tang ZM; Zhang L; Lu ZH
    Electrophoresis; 2007 Feb; 28(3):406-13. PubMed ID: 17191279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biocompatibility of surfaces for antibody microarrays: design of macroporous silicon substrates.
    Steinhauer C; Ressine A; Marko-Varga G; Laurell T; Borrebaeck CA; Wingren C
    Anal Biochem; 2005 Jun; 341(2):204-13. PubMed ID: 15907865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplexed sandwich assays in microarray format.
    Nielsen UB; Geierstanger BH
    J Immunol Methods; 2004 Jul; 290(1-2):107-20. PubMed ID: 15261575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple, rapid and large capacity ELISA for biologically active native and recombinant human IFN gamma.
    Gallati H; Pracht I; Schmidt J; Häring P; Garotta G
    J Biol Regul Homeost Agents; 1987; 1(3):109-18. PubMed ID: 3140597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparability study of the emerging protein array platforms with established ELISA procedures.
    Pang S; Smith J; Onley D; Reeve J; Walker M; Foy C
    J Immunol Methods; 2005 Jul; 302(1-2):1-12. PubMed ID: 15993890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of IFN-gamma produced by human purified NK cells following tumor cell stimulation: comparison of three IFN-gamma assays.
    Lion E; Smits EL; Berneman ZN; Van Tendeloo VF
    J Immunol Methods; 2009 Oct; 350(1-2):89-96. PubMed ID: 19733573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a fluorescent and colorimetric detection methods-based protein microarray for serodiagnosis of TORCH infections.
    Jiang L; Yu Z; Du W; Tang Z; Jiang T; Zhang C; Lu Z
    Biosens Bioelectron; 2008 Nov; 24(3):376-82. PubMed ID: 18524564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein microarray platform for the multiplex analysis of biomarkers in human sera.
    Urbanowska T; Mangialaio S; Zickler C; Cheevapruk S; Hasler P; Regenass S; Legay F
    J Immunol Methods; 2006 Oct; 316(1-2):1-7. PubMed ID: 16996079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse-phase versus sandwich antibody microarray, technical comparison from a clinical perspective.
    Järås K; Ressine A; Nilsson E; Malm J; Marko-Varga G; Lilja H; Laurell T
    Anal Chem; 2007 Aug; 79(15):5817-25. PubMed ID: 17605470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cancer protein microarray platform using antibody fragments and its clinical applications.
    Song S; Li B; Wang L; Wu H; Hu J; Li M; Fan C
    Mol Biosyst; 2007 Feb; 3(2):151-8. PubMed ID: 17245494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.